20 results
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
.
On August 8, 2022, we announced that we have received approval from the MoH and Ethics Committee of Soroka Medical Center to conduct our clinical … Inventory, respectively.
On August 8, 2022, we announced that we have received approval from the MoH and Ethics Committee of Soroka Medical Center to conduct
6-K
EX-99.1
SPRC
SciSparc Ltd
17 Jul 23
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
8:00am
in Israel, including approvals from the Soroka University Medical Center Ethics Committee and Israeli Ministry of Health.
The Company’s goal is to sell
6-K
EX-99.1
SPRC
SciSparc Ltd
11 Aug 22
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:42am
it received approval from the Ethics Committee of The Soroka University Medical Center, in Be’er-Sheva, Israel, to conduct the Company’s clinical trial.
“We
6-K
EX-99.1
slqjp7nj3gmk
29 Jun 22
SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
8:36am
6-K
lfc9c xjpzrfkh3l5m
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
6-K
EX-99.1
d1g9 w1m1
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
6-K
EX-99.1
4w4ppbjpaon6cha o48o
26 May 22
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
8:33am
6-K
32o 9vh56ryeii9o
26 May 22
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
8:33am
424B4
07blvljsjs9ek
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
fn1 f8t6wsshh2btgw
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
549kj4oc z2rv8l
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
sjbx r1on3cc2
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
7wfvyqwasrdy04va0cdm
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
20-F
jlzcn pk9
1 May 17
Annual report (foreign)
12:00am
- Prev
- 1
- Next